Literature DB >> 33488884

Transformation of Two Cases of Lung Adenocarcinoma into Pulmonary Sarcomatoid Carcinoma following Treatment.

Zhenyu Yang1, Yinfang Shen2, Junhong Jiang1, Ziyi Liu1, Chuanyong Mu1.   

Abstract

Accumulating evidence shows that histologic transformation is involved in the drug resistance of lung cancer. Moreover, it is common for lung adenocarcinoma to transform into small-cell lung cancer or squamous cell carcinoma; however, clinical cases with sarcomatoid transformation have been rarely reported. Thus, both the diagnosis and treatment of lung adenocarcinoma with sarcomatoid transformation remain difficult. Here, we discuss two patients with lung adenocarcinoma with sarcomatoid transformation-analyzing the diagnosis, clinical features, immunohistochemical characteristics, therapy, and prognosis-with the hope that this report will be used as a reference for future treatment of these patients.
Copyright © 2021 Zhenyu Yang et al.

Entities:  

Mesh:

Year:  2021        PMID: 33488884      PMCID: PMC7796848          DOI: 10.1155/2021/6661772

Source DB:  PubMed          Journal:  Can Respir J        ISSN: 1198-2241            Impact factor:   2.409


  14 in total

1.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

2.  Lung adenocarcinoma with sarcomatoid transformation after tyrosine kinase inhibitor treatment and chemotherapy.

Authors:  Min-Shu Hsieh; Mong-Wei Lin; Yi-Hsuan Lee
Journal:  Lung Cancer       Date:  2019-08-26       Impact factor: 5.705

3.  Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors.

Authors:  Lecia V Sequist; Belinda A Waltman; Dora Dias-Santagata; Subba Digumarthy; Alexa B Turke; Panos Fidias; Kristin Bergethon; Alice T Shaw; Scott Gettinger; Arjola K Cosper; Sara Akhavanfard; Rebecca S Heist; Jennifer Temel; James G Christensen; John C Wain; Thomas J Lynch; Kathy Vernovsky; Eugene J Mark; Michael Lanuti; A John Iafrate; Mari Mino-Kenudson; Jeffrey A Engelman
Journal:  Sci Transl Med       Date:  2011-03-23       Impact factor: 17.956

4.  Gain Fat-Lose Metastasis: Converting Invasive Breast Cancer Cells into Adipocytes Inhibits Cancer Metastasis.

Authors:  Dana Ishay-Ronen; Maren Diepenbruck; Ravi Kiran Reddy Kalathur; Nami Sugiyama; Stefanie Tiede; Robert Ivanek; Glenn Bantug; Marco Francesco Morini; Junrong Wang; Christoph Hess; Gerhard Christofori
Journal:  Cancer Cell       Date:  2019-01-14       Impact factor: 31.743

Review 5.  Review article: pulmonary sarcomatoid carcinomas: a practical overview.

Authors:  Giuseppe Pelosi; Angelica Sonzogni; Tommaso De Pas; Domenico Galetta; Giulia Veronesi; Lorenzo Spaggiari; Michela Manzotti; Caterina Fumagalli; Enrica Bresaola; Oscar Nappi; Giuseppe Viale; Juan Rosai
Journal:  Int J Surg Pathol       Date:  2009-01-04       Impact factor: 1.271

Review 6.  The role of TWIST1 in epithelial-mesenchymal transition and cancers.

Authors:  Qing-Qing Zhu; Chenhui Ma; Qian Wang; Yong Song; Tangfeng Lv
Journal:  Tumour Biol       Date:  2015-11-24

Review 7.  Resistance to molecularly targeted therapy in non-small-cell lung cancer.

Authors:  Tetsuhiko Asao; Fumiyuki Takahashi; Kazuhisa Takahashi
Journal:  Respir Investig       Date:  2018-10-04

Review 8.  Context-dependent EMT programs in cancer metastasis.

Authors:  Nicole M Aiello; Yibin Kang
Journal:  J Exp Med       Date:  2019-04-11       Impact factor: 14.307

9.  The EMT transcription factor, Twist1, as a novel therapeutic target for pulmonary sarcomatoid carcinomas.

Authors:  Tieju Liu; Xiulan Zhao; Xu Zheng; Yanjun Zheng; Xueyi Dong; Nan Zhao; Shihan Liao; Baocun Sun
Journal:  Int J Oncol       Date:  2020-01-29       Impact factor: 5.650

10.  Whole transcriptome targeted gene quantification provides new insights on pulmonary sarcomatoid carcinomas.

Authors:  Greta Alì; Rossella Bruno; Anello Marcello Poma; Ornella Affinito; Antonella Monticelli; Paolo Piaggi; Sara Ricciardi; Marco Lucchi; Franca Melfi; Antonio Chella; Sergio Cocozza; Gabriella Fontanini
Journal:  Sci Rep       Date:  2019-03-05       Impact factor: 4.379

View more
  1 in total

1.  Pten and p53 Loss in the Mouse Lung Causes Adenocarcinoma and Sarcomatoid Carcinoma.

Authors:  Sara Lázaro; Corina Lorz; Ana Belén Enguita; Iván Seller; Jesús M Paramio; Mirentxu Santos
Journal:  Cancers (Basel)       Date:  2022-07-28       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.